Jim Anderson Awarded 2021 Dreyfus Prize

James G. Anderson (left), the Philip S. Weld Professor in Chemistry at Harvard University, was awarded the 2021 Dreyfus Prize, conferred in Environmental Chemistry, on September 23. Scott Walter (right), President of the Camille and Henry Dreyfus Foundation, presented the Prize to Dr. Anderson in the company of his wife Shirine Boulos Anderson, Theodore Betley (Chair, Department of Chemistry), Daniel Nocera (Patterson Rockwood Professor of Chemistry and Dreyfus Board member), and Scott Siegel (Executive Director, Camille and Henry Dreyfus Foundation). A formal public ceremony to honor Dr. Anderson is planned to be held at Harvard in 2022. See this page for more details on Dr. Anderson’s research and his receipt of the Dreyfus Prize.

Matthew Tirrell Named Winner of 2022 ACS Award in Colloid Chemistry & Welch Institute Chair

Matthew Tirrell, Dean of the Pritzker School of Molecular Engineering at The University of Chicago and Chair of the Dreyfus Foundation’s Scientific Advisory Committee, has recently received two significant honors. Dr. Tirrell is the recipient of the 2022 American Chemical Society Award in Colloid Chemistry, which recognizes outstanding scientific contributions in the field. Further, the Welch Institute for Advanced Materials, a partnership between The Welch Foundation and Rice University focused on world-leading advanced materials research, has named Tirrell as the new chair of its Scientific Advisory Board.

Dr. Tirrell is a pioneering researcher in the fields of biomolecular engineering and nanotechnology, specializing in the manipulation and measurement of the surface properties of polymers, materials that consist of long, flexible chain molecules. His work combines microscopic measurements of intermolecular forces with the creation of new structures and has provided new insight into polymer properties, especially surface phenomena, such as adhesion, friction, and biocompatibility, and new materials based on self-assembly of synthetic and bioinspired materials. 

2021 Machine Learning in the Chemical Sciences & Engineering Awards

The Camille and Henry Dreyfus Foundation announces seven award recipients of the 2021 program for Machine Learning in the Chemical Sciences and Engineering, totaling $799,470. The Foundation anticipates that these projects will contribute new fundamental chemical insight and innovation in the field.

2021 Machine Learning in the Chemical Sciences & Engineering Awards:

Milad Abolhasani, North Carolina State University
An Autonomous Robo-Fluidic Microprocessor: Machine Learning-Guided Synthesis Process Development of Quantum Dots

Garnet Chan
, California Institute of Technology
New Opportunities for Machine Learning in Quantum Chemistry


Sriram Chandrasekaran
, University of Michigan
Predicting Moonlighting Metabolic Regulators Using Mechanistic Deep Learning


Qiang Cui
, Boston University
Understanding Protein Allostery using Machine Learning and Deep Mutation Data


Abigail Doyle
, University of California, Los Angeles
Artificial Intelligence for Chemical Reaction Prediction


Rafael Gomez-Bombarelli
, Massachusetts Institute of Technology
Adversarial Attacks on Interatomic Potentials for Active Learning and Inverse Design


Nicholas Jackson
, University of Illinois at Urbana-Champaign
Machine Learning Quantum Chemistry Over Coarse-Grained Fields

Dreyfus/ACS Symposium on Chemistry in Support of Human Health now online

The Dreyfus Foundation sponsored a symposium on Chemistry in Support of Human Health, the topic of the 2019 Dreyfus Prize, at the spring 2021 national meeting of the American Chemical Society. Videos of these talks are now available on YouTube, at the following links: Susan Richardson (U. of South Carolina), David Tirrell (Caltech), Carolyn Bertozzi (Stanford), Richard Friesner (Columbia), Chaitan Khosla (Stanford), Peter Schultz (Scripps Research Institute), Sangeeta Bhatia (MIT), and Robert Langer (MIT, recipient of the 2019 Dreyfus Prize).

Our New Executive Director, Scott A. Siegel

The Camille and Henry Dreyfus Foundation welcomes Dr. Scott A. Siegel as our new Executive Director. Dr. Siegel succeeds Dr. Mark J. Cardillo, who had served in the position since 2003.

Scott Siegel has spent more than 35 years as a scientific and business leader. Prior to joining the Foundation, Dr. Siegel was VP & Chief Business Officer for ATCC, a non-profit in the life sciences. He founded Milestone Life Sciences, a strategic advisory and partnering firm, and previously held senior leadership roles in public and private companies ranging from start-up to multinational, including COO at Ezose Sciences, VP at Redpoint Bio, and Executive Director at Johnson & Johnson. Dr. Siegel also served as VP for the non-profit Institute for Life Science Entrepreneurship. He has broad international experience, facilitating partnerships across North America, Europe and Asia.

“I am honored to join the Dreyfus Foundation as Executive Director and look forward to continuing our mission and building on a distinguished 75-year history. The chemical sciences play a role in essentially every aspect of our lives, and it is the Foundation’s aim to support the scientific community as it seeks to advance, interpret and disseminate knowledge across the spectrum of chemistry-related disciplines,” Dr. Siegel stated.

“The Board of Directors and I are thrilled that Scott Siegel has joined the Dreyfus Foundation,” said H. Scott Walter, President. “We look forward to Scott’s innovative and impactful leadership as the Foundation continues to strive to make a positive impact on the community we serve. We also thank Mark Cardillo for his substantial contributions to the Foundation’s mission over the past 18 years, a period of significant growth that included establishment of several new programs and events, including the Dreyfus Prize in the Chemical Sciences.”

Dr. Siegel earned his Ph.D. in Biochemistry from SUNY Downstate Medical Center, completed postdoctoral studies in Pharmacology at Yale University, and spent the early part of his career as an R&D leader in both large multinationals and fast-moving start-ups, including Becton, Dickinson and Co., Centocor and Phytera. He has more than 60 publications and patents and contributed to the development of 3 launched products, including as co-inventor of Remicade®, an anti-TNF therapy that has been used worldwide in the treatment of more than 3 million patients with autoimmune disorders. Dr. Siegel previously served as Adjunct Associate Professor of Microbiology at the University of Pennsylvania and more recently as Lecturer in the MBA Communications Program at the Wharton School.

The mission of the Camille and Henry Dreyfus Foundation is to advance the science of chemistry, chemical engineering, and related sciences as a means of improving human relations and circumstances throughout the world. Since its establishment in 1946 as a non-profit organization, the Foundation has awarded over $150 million in support of these goals. Current Dreyfus programs support young faculty accomplished in both research and teaching, further the exploration of emerging fields such as machine learning, recognize exceptional and original research that has advanced the field with the Dreyfus Prize, and fund lectureships at primarily undergraduate institutions.